7,408 Shares in Waters Corporation $WAT Acquired by Caisse DE Depot ET Placement DU Quebec

Key Points

• Caisse DE Depot ET Placement DU Quebec acquired 7,408 shares of Waters Corporation, valued at approximately $2.73 million, marking a significant institutional investment in the medical instruments supplier.
• Waters reported Q2 earnings showing an EPS of $2.95, which exceeded analysts' expectations, and had a revenue of $771.33 million, up 8.8% year-over-year.
• The stock has seen target price adjustments from various analysts, with the average target price set at $378.73, indicating a generally positive outlook for the company.

Caisse DE Depot ET Placement DU Quebec purchased a new position in shares of Waters Corporation (NYSE:WAT - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 7,408 shares of the medical instruments supplier's stock, valued at approximately $2,730,000.

Other hedge funds have also added to or reduced their stakes in the company. Olde Wealth Management LLC acquired a new stake in Waters during the 1st quarter worth approximately $25,000. Zions Bancorporation National Association UT acquired a new stake in Waters during the 1st quarter worth approximately $28,000. IFP Advisors Inc lifted its holdings in Waters by 118.9% during the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock worth $30,000 after purchasing an additional 44 shares during the last quarter. Whipplewood Advisors LLC lifted its holdings in Waters by 5,200.0% during the 1st quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock worth $39,000 after purchasing an additional 104 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in Waters during the 1st quarter worth approximately $41,000. 94.01% of the stock is owned by institutional investors and hedge funds.

Waters Price Performance

Waters stock opened at $297.32 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. Waters Corporation has a 52 week low of $275.05 and a 52 week high of $423.56. The stock has a market capitalization of $17.70 billion, a P/E ratio of 26.81, a price-to-earnings-growth ratio of 2.75 and a beta of 1.04. The stock has a fifty day moving average of $310.68 and a 200-day moving average of $339.44.

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, topping analysts' consensus estimates of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The company had revenue of $771.33 million during the quarter, compared to analysts' expectations of $745.96 million. During the same quarter in the previous year, the firm earned $2.63 EPS. Waters's revenue was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. On average, sell-side analysts expect that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

WAT has been the subject of a number of recent analyst reports. Jefferies Financial Group set a $385.00 target price on Waters and gave the company a "buy" rating in a research report on Monday, August 4th. Robert W. Baird cut their target price on Waters from $374.00 to $352.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. Deutsche Bank Aktiengesellschaft set a $315.00 target price on Waters and gave the company a "hold" rating in a research report on Tuesday, August 5th. Bank of America upped their target price on Waters from $370.00 to $375.00 and gave the company a "neutral" rating in a research report on Thursday, June 26th. Finally, UBS Group reiterated a "neutral" rating on shares of Waters in a research report on Tuesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Waters has an average rating of "Hold" and an average target price of $378.73.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.